(Q33718858)

28 July 2017

1 reference

title

Pneumococcal macrolide resistance--myth or reality? (English)

1 reference

28 July 2017

Amsden GW

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

Journal of Antimicrobial Chemotherapy

28 July 2017

published in

1 reference

28 July 2017

volume

44

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

1-6

1 reference

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Resistance patterns of Streptococcus pneumoniae and Haemophilus influenzae isolates recovered in Egypt from children with pneumonia. The Antimicrobial Resistance Surveillance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Erythromycin, clarithromycin, and azithromycin: are the differences real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Pharmacokinetics of Oral Azithromycin in Serum, Urine, Polymorphonuclear Leucocytes and Inflammatory vs Non-Inflammatory Skin Blisters in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.1.1

21 January 2018

Identifiers

DOI

10.1093/JAC/44.1.1

1 reference

28 July 2017

1 reference